24 related articles for article (PubMed ID: 38507288)
1. Further investigations into the genotoxicity of quinoxaline-di-N-oxides and their primary metabolites.
Liu Q; Zhang J; Luo X; Ihsan A; Liu X; Dai M; Cheng G; Hao H; Wang X; Yuan Z
Food Chem Toxicol; 2016 Jul; 93():145-57. PubMed ID: 27170491
[TBL] [Abstract][Full Text] [Related]
2. Deoxidation rates play a critical role in DNA damage mediated by important synthetic drugs, quinoxaline 1,4-dioxides.
Wang X; Zhang H; Huang L; Pan Y; Li J; Chen D; Cheng G; Hao H; Tao Y; Liu Z; Yuan Z
Chem Res Toxicol; 2015 Mar; 28(3):470-81. PubMed ID: 25626015
[TBL] [Abstract][Full Text] [Related]
3. High risk of adrenal toxicity of N1-desoxy quinoxaline 1,4-dioxide derivatives and the protection of oligomeric proanthocyanidins (OPC) in the inhibition of the expression of aldosterone synthetase in H295R cells.
Wang X; Yang C; Ihsan A; Luo X; Guo P; Cheng G; Dai M; Chen D; Liu Z; Yuan Z
Toxicology; 2016 Feb; 341-343():1-16. PubMed ID: 26802905
[TBL] [Abstract][Full Text] [Related]
4. The critical role of oxidative stress in the toxicity and metabolism of quinoxaline 1,4-di-N-oxides in vitro and in vivo.
Wang X; Martínez MA; Cheng G; Liu Z; Huang L; Dai M; Chen D; Martínez-Larrañaga MR; Anadón A; Yuan Z
Drug Metab Rev; 2016 May; 48(2):159-82. PubMed ID: 27285897
[TBL] [Abstract][Full Text] [Related]
5. The metabolism of carbadox, olaquindox, mequindox, quinocetone and cyadox: an overview.
Liu ZY; Sun ZL
Med Chem; 2013 Dec; 9(8):1017-27. PubMed ID: 23521002
[TBL] [Abstract][Full Text] [Related]
6. An appraisal on synthetic and pharmaceutical perspectives of quinoxaline 1,4-di-N-oxide scaffold.
Agrawal N; Bhardwaj A
Chem Biol Drug Des; 2022 Sep; 100(3):346-363. PubMed ID: 35610776
[TBL] [Abstract][Full Text] [Related]
7. Current status of quinoxaline and quinoxaline 1,4-di-N-oxides derivatives as potential antiparasitic agents.
Soto-Sánchez J; Ospina-Villa JD
Chem Biol Drug Des; 2021 Oct; 98(4):683-699. PubMed ID: 34289242
[TBL] [Abstract][Full Text] [Related]
8. Quinoxaline 1,4-di-N-Oxides: Biological Activities and Mechanisms of Actions.
Cheng G; Sa W; Cao C; Guo L; Hao H; Liu Z; Wang X; Yuan Z
Front Pharmacol; 2016; 7():64. PubMed ID: 27047380
[TBL] [Abstract][Full Text] [Related]
9. Advances in Metabolism and Metabolic Toxicology of Quinoxaline 1,4-Di-N-oxides.
An H; Li Y; Li Y; Gong S; Zhu Y; Li X; Zhou S; Wu Y
Chem Res Toxicol; 2024 Apr; 37(4):528-539. PubMed ID: 38507288
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
